← FDA Drug Approvals (Drugs@FDA)
QUILLIVANT XR
NDA · New Drug Application · Sponsor: NEXTWAVE · Approved 2012-09-27
Drug application
- FDA Application #
NDA202100- Application type
- New Drug Application
- Brand name
- QUILLIVANT XR
- Generic name
- METHYLPHENIDATE HYDROCHLORIDE
- Active ingredients
- METHYLPHENIDATE HYDROCHLORIDE
- Dosage form
- FOR SUSPENSION, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- NEXTWAVE
- Manufacturer
- NextWave Pharmaceuticals, Inc
- First approval
- 2012-09-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown